Wellington Management Group
IMVT icon

Wellington Management Group’s Immunovant IMVT Stock Holding History

Wellington Management Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
30,722
+2,197
+8% +$66.9K ﹤0.01% 1717
2026
Q1 		$709K Sell
28,525
-322
-1% -$8.34K ﹤0.01% 1734
2025
Q4 		$733K Buy
28,847
+755
+3% +$16.8K ﹤0.01% 1769
2025
Q3 		$453K Buy
28,092
+4,203
+18% +$68K ﹤0.01% 1893
2025
Q2 		$382K Sell
23,889
-1,141
-5% -$17.3K ﹤0.01% 1852
2025
Q1 		$428K Sell
25,030
-1,239
-5% -$25.9K ﹤0.01% 1842
2024
Q4 		$651K Sell
26,269
-2,425
-8% -$68.8K ﹤0.01% 1797
2024
Q3 		$818K Sell
28,694
-8,235
-22% -$243K ﹤0.01% 1746
2024
Q2 		$975K Sell
36,929
-370,725
-91% -$10.5M ﹤0.01% 1683
2024
Q1 		$13.2M Buy
407,654
+112,634
+38% +$4.11M ﹤0.01% 1054
2023
Q4 		$12.4M Buy
295,020
+126,412
+75% +$4.65M ﹤0.01% 1055
2023
Q3 		$6.47M Buy
+168,608
New +$3.81M ﹤0.01% 1214

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group's IMVT Position: Q2 2026 in Review

Wellington Management Group increased its Immunovant (IMVT) stake by 7.7% in Q2 2026, buying an estimated $66.9K and bringing the position to 30,722 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1717.

Wellington Management Group first reported a position in IMVT in Q3 2023 and has held it in 12 quarters since. The position peaked at $13.2M in Q1 2024. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Wellington Management Group held 30,722 shares of Immunovant worth $1.18M as of Q2 2026.
  • Wellington Management Group bought 2,197 Immunovant shares in Q2 2026, an estimated $66.9K.
  • Immunovant made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1717 holding.
  • Wellington Management Group first reported a position in Immunovant in Q3 2023 and has held it in 12 quarters since.
  • Wellington Management Group's Immunovant position peaked at $13.2M in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.